Baxter International | BAX - أصول متداولة





أصول متداولة تغيير تاريخ
Abbott USD 25.51B 488M 2026-03
AngioDynamics USD 161.35M 4.69M 2025-09
Artivion USD 357.52M 566K 2026-03
AtriCure USD 345.53M 31.84M 2026-06
Avanos Medical USD 325M 30.4M 2026-03
Baxter International USD 6.99B 142M 2026-06
Becton, Dickinson and Co. USD 8.01B 1.18B 2026-03
Boston Scientific USD 8.68B 110M 2026-03
Cooper Companies USD 2.3B 166M 2026-03
Dexcom USD 4.09B 245.1M 2026-06
Edwards Lifesciences USD 6.23B 510.2M 2026-03
Fresenius EUR 11.03B 1.03B 2025-12
Globus Medical USD 2.2B 72.51M 2026-03
Halozyme Therapeutics USD 1B 177.83M 2026-03
ICU Medical USD 1.21B 22.69M 2026-03
Inogen USD 203.72M 594K 2025-09
Insulet USD 1.71B 204.5M 2026-03
Integra LifeSciences USD 1.19B 19.46M 2026-06
Intuitive Surgical USD 12.33B 807.5M 2026-06
J&J USD 59.77B 601M 2026-06
Laboratory Of America USD 3.81B 743.9M 2026-06
Medtronic USD 24.07B 75M 2025-12
Merit Medical Systems USD 1.11B 10.46M 2026-06
Quest Diagnostics USD 2.84B 278M 2026-06
Smith & Nephew USD 4.63B 169M 2025-12
Stryker USD 14.42B 1.08B 2026-06
Tandem Diabetes Care USD 887.1M 268.96M 2026-03
Teleflex USD 1.86B 78.67M 2026-03
Terumo JPY 861.04B 45.48B 2026-03
Zimmer Biomet Holdings USD 4.96B 157.4M 2026-03